Content Navigation
( All
None )
| Target and Pathway |
Top |
| Target(s) |
Glucagon-like peptide 1 receptor (GLP1R) |
Target Info
|
Agonist |
[2] |
| References |
Top |
| REF 1 |
ClinicalTrials.gov (NCT03985293) A 16 Week Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Type 2 Diabetes Mellitus. U.S. National Institutes of Health.
|
| REF 2 |
Differential GLP-1R Binding and Activation by Peptide and Non-peptide Agonists. Mol Cell. 2020 Nov 5;80(3):485-500.e7.
|
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.
